All articles tagged with #narcolepsy
The FDA approved Takeda’s Orzeyful, a twice-daily orexin receptor agonist for narcolepsy type 1, a first-in-class treatment that improved daytime wakefulness and reduced sleepiness in Phase 3 trials, offering potential benefits over current therapies and hinting at broader neurological applications, though long-term safety and applicability remain under study.
Nazir Stackhouse, a Green Bay Packers rookie defensive tackle, has narcolepsy, a condition he has managed throughout his football career. Despite challenges like falling asleep during games and meetings, he uses medication and strategies to stay alert. He hopes his openness about his condition will inspire others and demonstrates resilience and determination to succeed in the NFL.
Azurity Pharmaceuticals is recalling a lot of its Zenzedi 30 mg medication used to treat ADHD and narcolepsy due to potential mix-up with an antihistamine drug, Carbinoxamine Maleate, found in some packages. The wrong pills could lead to undertreatment of symptoms, drowsiness, and an increased risk of accidents and injury, particularly for those participating in activities requiring focus and alertness. Consumers are advised to stop using the affected drug, contact their healthcare provider if they have experienced any issues, and report any medical problems to the FDA.
Julie Faenza's significant sleep problems were attributed to anxiety and depression, but after a scary incident while driving, she began a year-long search that resulted in the discovery of a long-overlooked disorder. Faenza was diagnosed with Type 1 narcolepsy, a chronic neurological disorder that impairs the brain's sleep/wake cycles and causes excessive daytime sleepiness. Such a delay in diagnosis is not uncommon, and the lack of education about sleep disorders in medical school remains a barrier to timely diagnosis. Faenza wishes she had heeded advice her mother had given her years earlier about the importance of knowledge and self-advocacy in medical matters.